April 4, 2022, has defined my life for almost four years. I never imagined that I would go from driving to a friend’s house ...
CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...
Neurological diseases affect the nervous system, including the brain, spinal cord, and peripheral nerves that carry signals throughout your body. These conditions can disrupt movement, thinking, mood, ...